Correlation Between Vor Biopharma and Evaxion Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vor Biopharma and Evaxion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vor Biopharma and Evaxion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vor Biopharma and Evaxion Biotech AS, you can compare the effects of market volatilities on Vor Biopharma and Evaxion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vor Biopharma with a short position of Evaxion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vor Biopharma and Evaxion Biotech.

Diversification Opportunities for Vor Biopharma and Evaxion Biotech

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Vor and Evaxion is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Vor Biopharma and Evaxion Biotech AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaxion Biotech AS and Vor Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vor Biopharma are associated (or correlated) with Evaxion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaxion Biotech AS has no effect on the direction of Vor Biopharma i.e., Vor Biopharma and Evaxion Biotech go up and down completely randomly.

Pair Corralation between Vor Biopharma and Evaxion Biotech

Considering the 90-day investment horizon Vor Biopharma is expected to generate 0.62 times more return on investment than Evaxion Biotech. However, Vor Biopharma is 1.61 times less risky than Evaxion Biotech. It trades about -0.04 of its potential returns per unit of risk. Evaxion Biotech AS is currently generating about -0.04 per unit of risk. If you would invest  436.00  in Vor Biopharma on January 7, 2025 and sell it today you would lose (382.00) from holding Vor Biopharma or give up 87.61% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Vor Biopharma  vs.  Evaxion Biotech AS

 Performance 
       Timeline  
Vor Biopharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vor Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in May 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Evaxion Biotech AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Evaxion Biotech AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Vor Biopharma and Evaxion Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vor Biopharma and Evaxion Biotech

The main advantage of trading using opposite Vor Biopharma and Evaxion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vor Biopharma position performs unexpectedly, Evaxion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaxion Biotech will offset losses from the drop in Evaxion Biotech's long position.
The idea behind Vor Biopharma and Evaxion Biotech AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stocks Directory
Find actively traded stocks across global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios